IngentaConnect Weight gain associated with psychotropic drugs

Author: Masand P.S.¹

Source: Expert Opinion on Pharmacotherapy, Volume 1, Number 3, March 2000 , pp. 377-389(13)

Abstract:

Weight gain is a common adverse effect of psychotropic drugs. Clinically significant weight gain puts the patient at risk for coronary heart disease, hypertension, Type II diabetes, dyslipidaemia and cancer, and can lead to non-compliance, with the probability of relapse and subsequent (re)hospitalisation. This review focuses on specific drug classes such as antipsychotics, antidepressants, mood stabilisers and anxiolytics that have a propensity to induce clinically significant weight gain. Patients should be informed of potential drug-induced weight gain and instructed in the importance of weight management techniques (e.g., proper nutrition, physical exercise, behaviour modification). Individual patient-risk profiles should also be assessed. To ensure adherence to treatment, a proactive physician-patient relationship is essential. Patient compliance and quality-of-life issues are addressed. For appropriate medication selection, the clinician should consider the weight gain potential of various psychotropic agents.

Keywords: antidepressants; antipsychotics; compliance; mood stabilisers; obesity; psychotropic drugs; weight gain; weight management

Document Type: Review article

Affiliations: 1: State University of New York Upstate Medical University Department of Psychiatry, 750 E. Adams Street, Syracuse, NY 13210, USA. GivensS@mailbox.hscsyr.edu

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$99.00 plus tax